Major shareholder Jan Stahlberg has significantly increased his investment in DiaMedica Therapeutics, Inc. (NASDAQ: DMAC) by acquiring 59,788 shares on August 22, 2023. The shares were...
Cytokinetics, Inc. (NASDAQ: CYTK) has received a price target increase from Citigroup, which raised its target from $77.00 to $84.00, as detailed in a research report...
The utility sector is experiencing a remarkable transformation in 2025, emerging as a surprising leader in the stock market. Traditionally viewed as a defensive investment, utilities...
Royce & Associates LP has taken a significant step by investing approximately $4.19 million in Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) during the first quarter of 2023....
Tesla (NASDAQ: TSLA) has announced its earnings results for the second quarter of 2025. Released on July 23, 2025, after market hours, the update letter provides...
Cadence Design Systems (NASDAQ: CDNS) has seen its price target increased from $340.00 to $370.00 by Loop Capital, according to a research report released on Monday....
